Lp(a), aortic valve stenosis, and atherosclerosis

30 August 2026 (17:42 - 17:54)

Organised by:

About the speaker

Doctor Simon Kraler

University Heart Center, Zurich (Switzerland)

4 More presentations in this session

Presentation thumbnail

Remnant cholesterol and triglyceride-rich lipoproteins: what human genetics tells us about causality beyond LDL

Professor A. Tybjaerg-Hansen (Copenhagen, DK)

Presentation thumbnail

Emerging mechanisms controlling immunoinflammatory response during atherogenesis

Miss M. Depuydt (Amsterdam, NL)

Presentation thumbnail

Targeting deoxyribonucleic acid and ribonucleic acid in the context of lipid-lowering and vascular disorders

Professor N. Bouatia-Naji (Paris, FR)

Presentation thumbnail

New targets for lipid-lowering and atherosclerosis: what's beyond low-density lipoprotein? - discussion

Access the full session

Session thumbnail

New targets for lipid-lowering and atherosclerosis: what's beyond low-density lipoprotein?

The Event

Event poster

ESC Congress 2026

30 August 2026 17:42 CET

You may be interested in

Webinar

Lipoprotein(a): current role and future perspectives in cardiovascular medicine

31 October 2025

Congress Presentation

Are traditional cardiovascular risk factors also related to aortic valve stenosis?

20 May 2023

Congress Presentation

Association between lipoprotein (a) level and chronic cardio-renal syndrome in patients with coronary artery disease

29 June 2021

Congress Presentation

Lp(a) is not associated with arterial stiffness: A Mendelian Randomization Study.

26 August 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources